Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more

Heart Failure

Prevention & Chronic Conditions
The Timing for Primary Prevention ICD in the Current Era of Pharmacotherapy
Author(s): Anastasia Shchendrygina , Amin Yehya , Hadi Skouri Added: 4 months ago

Heart Failure
Author(s): Owais Dar , Espeed Khoshbin Added: 1 year ago
Heart transplantation and left ventricular assist devices (LVADs) are crucial options for patients with advanced heart failure, but determining the right timing for intervention is key to optimizing outcomes. This webinar, moderated by Dr Owais Dar from the Royal Brompton and Harefield Hospitals, will explore the decision-making process behind patient referrals, weighing the benefits and risks of… View more

Heart Failure
Timing of Heart Transplantation & LVADs
Author(s): Espeed Khoshbin , Owais Dar Start date: Nov 05, 2024
Heart transplantation and left ventricular assist devices (LVADs) are crucial options for patients with advanced heart failure, but determining the right timing for intervention is key to optimizing outcomes. This webinar, moderated by Dr Owais Dar from the Royal Brompton and Harefield Hospitals, will explore the decision-making process behind patient referrals, weighing the benefits and risks of… View more

Heart Failure
WATCH THE SYMPOSIUM HERE
Start date: May 13, 2024 End date: May 13, 2024
Radcliffe Medical Education is hosting a symposium entitled 'A Race Against Time: Accelerating the Adoption of GDMT in Heart Failure' at theHeart Failure Association (HFA)in Lisbon, PT, on Monday 13th May 2024 at 12:30 - 13:30 UTC+1.Add to your calendar.OverviewThis symposium will focus on the importance of accurate and rapid diagnosis for patients empowering physicians to promptly initiate… View more

Heart Failure
Time in Target Ambulatory Blood Pressure Range Linked to Lower CV Risk
Added: 3 months ago Source:  Radcliffe Cardiology
A new meta-analysis suggests that the more time an individual's ambulatory blood pressure (ABP) is within the target range proposed by the 2024 European Society of Cardiology (ESC) guidelines, the lower their risk of mortality and cardiovascular events.¹ The findings also highlight that office blood pressure measurements frequently misclassify patients with regard to their actual blood pressure… View more

Demographic

Guidelines & Statements
Added: 3 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Cardiovascular Renal Metabolic

Heart Failure
A Race against Time: Accelerating the Adoption of GDMT in Heart Failure
Author(s): Antoni Bayés-Genís , Lisa Anderson , Stephen J Greene Added: 1 year ago
This symposium emphasises the critical role of accurate and rapid diagnosis in enabling physicians to quickly start guideline-directed medical therapy. Prof Antoni Bayés-Genís (University Hospital Germans Trias i Pujol, Barcelona, ES), Dr Lisa Anderson (St George's Hospital, London, UK) and Dr Stephen Greene (Duke University School of Medicine, Durham, US) discuss and reflect on current… View more

Heart Failure
HFSA 25: The ATTRibute-CM Trial
Author(s): Ahmad Masri Added: 1 month ago
HFSA 2025 - Post hoc analysis of ATTRibute-CM reveals significant reduction in cardiovascular mortality and death after 30 months of acoramidis in patients with ATTR-CM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss a post hoc exploratory analysis from the ATTRibute-CM trial examining the timing and magnitude of cardiovascular outcome reductions with acoramidis in… View more

Heart Failure
Robert M Wachter
Robert M Wachter is Professor and Chair of the Department of Medicine at UCSF and a leading figure in hospital medicine, having coined the term “hospitalist” in 1996. He is the author of six books, including the New York Times bestseller The Digital Doctor, with his latest, A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future, forthcoming from Portfolio/Penguin in… View more